Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02289950
Title A Study to Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination With Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD) in Subjects With Low CA125 Platinum-Sensitive Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Morphotek
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | GBR | ESP | DEU | BEL

Facility Status City State Zip Country Details
Phoenix Arizona United States Details
Los Angeles California United States Details
Orange California United States Details
Roseville California United States Details
Sacramento California United States Details
Aurora Colorado United States Details
Miami Florida United States Details
Miramar Florida United States Details
Orlando Florida United States Details
Sarasota Florida United States Details
Tampa Florida United States Details
Atlanta Georgia United States Details
Augusta Georgia United States Details
Savannah Georgia United States Details
Chicago Illinois United States Details
Lexington Kentucky United States Details
Louisville Kentucky United States Details
Baltimore Maryland United States Details
Boston Massachusetts United States Details
Detroit Michigan United States Details
Minneapolis Minnesota United States Details
Grand Island Nebraska United States Details
New York New York United States Details
Chapel Hill North Carolina United States Details
Charlotte North Carolina United States Details
Winston-Salem North Carolina United States Details
Centerville Ohio United States Details
Cincinnati Ohio United States Details
Cleveland Ohio United States Details
Columbus Ohio United States Details
Chattanooga Tennessee United States Details
Knoxville Tennessee United States Details
Austin Texas United States Details
Annandale Virginia United States Details
Charlottesville Virginia United States Details
Edegem Antwerpen Belgium Details
Brussels Bruxelles Belgium Details
Hasselt Limburg Belgium Details
Gent Oost-Vlaanderen Belgium Details
Leuven Belgium Details
Liege Belgium Details
Ulm Baden-Württemberg Germany Details
Chemnitz Sachsen Germany Details
Berlin Germany Details
Dresden Germany Details
Essen Germany Details
Napoli Campania Italy Details
Roma Lazio Italy Details
Bari Puglia Italy Details
Avellino Italy Details
Bologna Italy Details
Milano Italy Details
Napoli Italy Details
Perugia Italy Details
Chuo-Ku Japan Details
Hidaka-City Japan Details
Kashiwa-City Japan Details
Koto-Ku Japan Details
Kurume-City Japan Details
Matsuyama-City Japan Details
Minato-Ku Japan Details
SuntoGun Japan Details
Palma de Mallorca Baleares Spain Details
Cordoba Córdoba Spain Details
Madrid Spain Details
Sabadell Spain Details
Plymouth Devon United Kingdom Details
London United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field